Compare · PI vs TMO
PI vs TMO
Side-by-side comparison of Impinj Inc. (PI) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- PI operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $248.91B, about 42.4x PI ($5.87B).
- Over the past year, PI is down 5.3% and TMO is up 29.7% - TMO leads by 35.0 points.
- TMO has been more active in the news (7 items in the past 4 weeks vs 5 for PI).
- TMO has more recent analyst coverage (25 ratings vs 21 for PI).
- Company
- Impinj Inc.
- Thermo Fisher Scientific Inc
- Price
- $191.02-0.59%
- $696.50+3.45%
- Market cap
- $5.87B
- $248.91B
- 1M return
- +7.47%
- +7.40%
- 1Y return
- -5.26%
- +29.72%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2016
- News (4w)
- 5
- 7
- Recent ratings
- 21
- 25
Impinj Inc.
Impinj, Inc. operates a cloud connectivity platform. Its platform, which comprises multiple product families, wirelessly connects individual items and delivers data about the connected items to business and consumer applications. The company's platform comprises endpoint ICs, a miniature radios-on-a-chip that attaches to a host item and includes a number to identify the item. Its platform also consists of systems products that comprise reader ICs, readers, and gateways to wirelessly provide power to and communicate bidirectionally with endpoint ICs on host items, as well as to read, write, authenticate, and engage the endpoint ICs on those items; and software and algorithms that enables its partners to deliver use cases, such as retail self-checkout and loss prevention, and warehouse pallet and carton tracking to end users. The company primarily serves retail, supply chain and logistics, aviation, automotive, healthcare, industrial and manufacturing, sports, food, datacenter, travel, banking, and linen and uniform tracking sectors through distributors, system integrators, value-added resellers, and software solution partners in the Americas, the Asia Pacific, Europe, the Middle East, and Africa. Impinj, Inc. was incorporated in 2000 and is headquartered in Seattle, Washington.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest PI
- SEC Form 4 filed by Impinj Inc.
- Impinj to Announce Third-Quarter 2026 Financial Results
- CHIEF EXECUTIVE OFFICER Diorio Chris Ph.D. converted options into 3,041 shares and covered exercise/tax liability with 1,197 shares, increasing direct ownership by 0.52% to 356,265 units (SEC Form 4) to satisfy withholding tax
- CHIEF FINANCIAL OFFICER Baker Cary converted options into 1,075 shares and covered exercise/tax liability with 424 shares, increasing direct ownership by 0.81% to 81,039 units (SEC Form 4) to satisfy withholding tax
- CHIEF FINANCIAL OFFICER Baker Cary sold $1,645,020 worth of shares (8,892 units at $185.00) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 80,388 units (SEC Form 4)
- Director Washington Miron sold $138,608 worth of shares (800 units at $173.26), decreasing direct ownership by 16% to 4,354 units (SEC Form 4)
- CHIEF EXECUTIVE OFFICER Diorio Chris Ph.D. gifted 10,000 shares, decreasing direct ownership by 3% to 354,421 units (SEC Form 4)
- Impinj Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Impinj Announces Exchange of 1.125% Convertible Senior Notes due 2027
- Impinj to Participate in Piper Sandler Growth Frontiers Conference
Latest TMO
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- SEC Form 4 filed by Director Keith R. Alexandra
- Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
- Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)